Yuvraj

Selcia and Gilead Sciences Extend Liver Disease Drug Discovery Collaboration

Selcia Limited, a leading contract research organisation, announced a drug discovery collaboration agreement with Gilead Sciences, Inc. Building on an established partnership following significant...

Quintiles and London Genetics Alliance T0 Enchance Drug Discovery and Development

Quintiles, the world’s leading bio pharmaceutical services company, and London Genetics, an expert in the use of pharmacogenetics in drug discovery and development, today...

World’s Leading Clinical Trial Investigator Portal Solution Released By InnovoCommerce LLC

InnovoCommerce, LLC released the market leading innovoPOINT® 3.1 clinical and investigator portal solution for life science organizations. This solution, built on the Microsoft® SharePoint®...

Micell Technologies Enrolls First Patient in DESSOLVE I First-In-Human Study of MiStent DES

Micell Technologies,announced it has enrolled at Mercy Hospital in Auckland, New Zealand, the first patient in DESSOLVE I (DES with Sirolimus and a bioabsorbable...

BG Medicine Announces FDA Clearance of its Galectin-3 Test for Use in Patients with Chronic HF

BG Medicine, Inc., a U.S.-based life sciences company, announced that the U.S. FDA has cleared the company’s Galectin-3 test for use in conjunction with...

European Medicines Agency and European Network of Centres for Pharmacoepidemiology and Pharmacovigilance launch E-Register

The European Medicines Agency and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) have launched the ENCePP E-Register of Studies. This electronic...

Vertex Completes New Drug Application for Telaprevir for Hepatitis C

Vertex Pharmaceuticals Incorporated announced that it has completed the submission of a New Drug Application (NDA) to the FDA seeking approval for telaprevir, Vertex's...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read